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Abstract
Background: In Juvenile Idiopathic Arthritis (JIA) the temporomandibular joint (TMJ) can be involved leading to pain,
dysfunction and growth disturbances of the mandible and associated structures. There may be value to a three minute
screening protocol allowing the rheumatologist to detect TMJ involvement systematically. Reliability and validity of the
TMJ protocol for detecting TMJ co-morbidity were determined in 74 consecutive JIA patients.
Methods: The assessments of the rheumatologist and of a reference examiner (RE) were compared and validity of the
TMJ protocol was established using the disease activity (JADAS-27) as an external reference.
Results: The internal consistency of the protocol was 0.73 (Cronbach’s alpha). The inter-examiner agreement between the
rheumatologist and the RE varied between 0.25 and 0.87 (Cohen’s Kappa). Sensitivity and specificity, with the JADAS “3.8”
indicating minimal disease activity, were 0.57 and 0.77 respectively. The area under the curve (AUC) was 0.70. A cut-off
value of two positive items was found to be an optimal threshold to select the patients with likely TMJ involvement.
Conclusions: The use of the protocol is feasible in everyday clinical practice. Reliability and validity aspects were
satisfactory. The screening protocol for TMJ involvement provides the rheumatologist with systematic and focused TMJ
information which relates to the JIA disease activity (JADAS-27).
Keywords: Juvenile idiopathic arthritis, Temporomandibular joint, Disease activity
Background
Arthritis of the temporomandibular joint (TMJ) can be a
manifestation of Juvenile Idiopathic Arthritis (JIA), with im-
pact on the masticatory system [1,2]. It is described as
occurring in all JIA subtypes, in recent onset as well as
long-standing disease [3,4]. Failure to diagnose and treat
TMJ arthritis may have severe consequences. When the
TMJ is affected, children may have masticatory dysfunction,
like pain on biting, chewing and yawning [5]. Mandibular
growth can also be impaired and facial asymmetries may
develop [6-9]. Therefore, the pediatric rheumatologist could
find value in a brief screening TMJ examination protocol
for patients with JIA, whereby TMJ dysfunction could be
detected and managed. Based on the result of the assess-
ments, the rheumatologist would be able to detect actual
TMJ dysfunction and treat the underlying inflammation
using aggressive management. Additionally, patients could
be referred for a more comprehensive examination to a
multidisciplinary team consisting of a maxillofacial surgeon,
orthodontist, orofacial pain specialist and/or physical ther-
apist for further diagnosis and management of possible
complications of JIA. Pediatric rheumatologists may not be
trained to perform a full diagnostic examination or do not
have time in all consecutive patients. By completing the
3 minute screening protocol, all rheumatologists would be
able to monitor TMJ status systematically rather than re-
frain from a full evaluation of the TMJ and related struc-
tures or examine on a non-systematic basis. Therefore a
short examination protocol, derived from a validated model
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[10,11] was constructed, to be used by all rheumatologists
in children and young adults with JIA.
The severity of TMJ involvement in JIA has been re-
ported to be directly related to inflammatory variables:
symptoms of TMJ dysfunction coincide with flares of
disease activity [5]. Moreover, clinical and subjective
orofacial involvement (e.g., temporomandibular signs
and symptoms) appears to be related to disease activity
in patients with JIA during the most recent two years,
using the International League against Rheumatism
classification (ILAR) [12]. For these reasons we used
the JADAS-27 as an external clinical reference for val-
idation of the TMJ protocol. The JADAS-27 reflects the
overall JIA activity and does not include assessment of
the masticatory system. A correlation between the total
score of the TMJ protocol and the JADAS-27 may sup-
port its clinical utility.
Our aim was to test the TMJ examination protocol for
internal consistency, reliability and concurrent validity
against the JADAS-27 in a consecutive series of patients
diagnosed with JIA.
Methods
Research was in compliance with the Helsinki Declaration.
The Medical-Ethics Committee of the UMC Utrecht ap-
proved all study procedures (12-604/C).
Participants
Seventy eight consecutive patients with JIA, classified by
the International League Against Rheumatism (ILAR) cri-
teria [13], between 5 and 17 years of age, were selected for
the study and recruited from the outpatient clinic of the
pediatric department of rheumatology & immunology at
the University Medical Center Utrecht, The Netherlands.
They were requested to participate by mail two weeks be-
fore their consultation with the rheumatologist. Informed
consent was obtained in 76 out of 78 patients. Reasons for
non-participation were psychological due to fear of being
examined by a dentist. Patients, either in remission or with
active disease, were examined between December 2013 and
January 2014. Those with dental problems, a history of fa-
cial trauma, or pre-existing cranio-maxillofacial disorder
unrelated to JIA were excluded. Patient characteristics and
subgroup diagnoses are described in Table 1.
Procedure
The pediatric rheumatologists were trained for the TMJ
examination before the start of the project by a dentist
(MHS) who is an orofacial pain and temporomandibular
joint dysfunction specialist experienced with the clinical
examination of the masticatory system and the examin-
ation of children with JIA. For this reason the examiner
was considered as the Reference Examiner (RE). A two
hour training session was sufficient to explain the aim of
the study, the protocol and the clinical examination to
the rheumatologists, who were then tested by the RE on
four patients in the clinical setting. Written instructions
regarding the protocol were handed out. Four weeks
after the last training session the study started.
Clinical examination
On the day of consultation, the patient was first exam-
ined by the rheumatologist. Within 15–30 minutes, the
patient was then examined by the dentist, blinded to the
findings of the rheumatologist. The TMJ protocol con-
sisted of five history related questions and six clinical
examination items (Figure 1). History related items were:
Table 1 Patient characteristics
n Mean SD Min - Max
Examined 76
Enrolled (F:M) 74 (2.4:1)
Age (SD) yrs 11.9 3.8
Age at onset (SD) yrs 7.5 3.9
Disease duration (SD) yrs 4.5 3.4
JIA diagnosis:
Oligo ANA pos 17/23%
Oligo ANA neg 15/20.3%
Oligo extended 6 /8.1%
Poly RF pos 16/21.6%
Poly RF neg 8/10.8%
Systemic JIA 8 (10.8)%
ERA HLA B27 pos 3/4%
Psoriatic Arthritis 1/1.4%
Medication:
NSAID 36/48.6%
Systemic steroids 4/5.4%
DMARDS 41/55.4%
Biologics 22/29.7%
Orthodontic tx 7/9.5%
JADAS-27 74 3.6 5.8 0 – 37.5
MMO 74 45.3 7.7 25 – 60
MMO age≤ 10 27 43.6 5.4 25 – 52
MMO age > 10 47 46.3 8.7 25 – 60
MMO≤ 40 21 35.9 4.2 25 – 40
MMO≤ 35 8 32.1 4.5 25 – 35
MMO≤ 30 2 - - 25 – 27
Number of patients referred to as n / % (unless indicated otherwise), and
MMO as mm
Pt: patients; F: female; M: male; yrs: years, SD = standard deviation, n = number
of patients. ANA: anti-nuclear antibodies; oligo: oligoarticular; poly: polyarticular;
ERA: enthesitis-related arthritis; PsoA: psoriatic arthritis; NSAIDs: non-steroidal
anti-inflammatory drugs; DMARDs: disease modifying anti-rheumatic drugs.
Orthodontic tx: coincidental orthodontic treatment (patients being in treatment
and wearing appliances not for JIA related TMJ issues). MMO: maximum mouth
opening; JADAS-27: Juvenile Arthritis Disease Activity Score.
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problems with chewing, eating more slowly than rela-
tives, difficulties in biting and eating hard food, pain on
chewing and limited mouth opening. The clinical exam-
ination included measuring maximum mouth opening
(MMO) in millimeters between the incisal edges of the
upper and lower front teeth with a metal ruler to the
nearest mm (Figure 2a). Patients were encouraged to
open actively as wide as possible. They were instructed
not to pay attention to pain that might occur. The cut-
off value for restricted mouth opening was ≤ 35 mm
in ≤ 10 year olds and ≤ 40 mm in patients > 10 years
[14]. The examiner assessed audible crepitation (with-
out a stethoscope) during opening and closing, pain on
maximum mouth opening, supplemented by inspection
regarding asymmetry (chin, face) and mandibular retro-
gnathia. Mandibular deviation on maximum opening
(>2 mm) is measured with the side of a metal ruler po-
sitioned in the mid-sagittal plane. The movement of a
point on the chin with regard to the side of the ruler
was assessed (Figure 2b). Other assessments were not
excluded. If an item scored positive, “1” was assigned,
otherwise “0”, with a resulting total score of the proto-
col ranging from 0 to 11. We conceptualized “at least 1
positive score” as an indication for potential TMJ
involvement. Composite scores were constructed for
the history related items (Fh, total score ranging from
0–5) and the 6 examination related items (Fe, total
score ranging from 0–6).
To test the concurrent validity of the protocol, the ju-
venile arthritis disease activity score (JADAS-27) [15]
was used as an external reference to measure actual dis-
ease activity.
The JADAS consists of the following variables: 1) phys-
ician global rating of overall disease activity measured
on a 10-cm horizontal visual analog scale (VAS) or a
21-numbered circle VAS (0: no activity; 10: maximum
activity for both VAS); 2) parent/child ratings of well-
being and pain, assessed on a 10-cm horizontal VAS or
a 21-numbered circle VAS (0 best; 10 worst for both
VAS); 3) number of active joints, assessed in 71, 27, or
10 joints (JADAS-71, JADAS-27, and JADAS-10, re-
spectively); and 4) Westergren erythrocyte sedimenta-
tion rate (ESR), normalized to a 0–10 scale. The final
result is the sum of the scores of its four components,
with a global score of 0–101, 0–57, and 0–40 for the
JADAS-71, JADAS-27, and JADAS-10, respectively. We
used the JADAS-27, because it is more feasible than
the JADAS-71, and not as limited as the JADAS-10.
Figure 1 Format of the TMJ screening protocol.
Figure 2 Measurement of parameters of maximum mouth opening (a) range of motion (b) lateral deviation on MMO > 2mm; in this illustration
there is no lateral deviation.
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Moreover the TMJ’s are not included in the JADAS-27,
which makes this score more appropriate for validation
of the TMJ protocol than the JADAS-71. Different cut-
off values have been validated for the JADAS-27. Min-
imal disease activity has been defined with a score
below “2” for oligoarticular JIA, and below “3.8” for
polyarthritis [16]. In our study, we used these two
scores of disease activity to calculate cut-off points of
the protocol to indicate TMJ dysfunction. The JADAS-27
was assessed during the routine clinical visit. Blood was
drawn only in case of higher disease activity compared
to former visits or for drug monitoring purposes. In the
other cases ESR from a former visit was used (maximum
three months before the examination) to calculate the
JADAS-27.
Statistical analysis
The internal consistency of the protocol was determined
using Cronbach’s alpha. Inter-examiner reliability of the
individual items, composite scores Fh and Fe, and the
total score, as assessed by the RE and the rheumatolo-
gist, was determined using Cohen’s Kappa [17].
Correlation between the outcome variables and JADAS
was tested using Pearson’s correlation. Sensitivity, specificity,
positive predictive value (PPV) and negative predictive
value (NPV) were established using the test result of
the rheumatologist. ROC analysis was performed to cal-
culate the cut-off point of the TMJ examination proto-
col. All statistical tests were 2-sided. P-values less than
0.05 were considered significant. All analyses were car-
ried out with the statistical package SPSS version 20 for
Windows (IBM corporation, USA).
Results
A group of 76 patients, female to male ratio 2.4:1 (Table 1),
was examined. Two patients were excluded after the exam-
ination because of a dental abcess and because of suspected
inner ear involvement. The final group of 74 patients had a
mean age of 11.9 yrs (SD 3.8) (Table 1). The rheumatolo-
gists were of opinion that the standardized TMJ evaluation
could easily be included in the regular consultation time at
the outpatient clinic.
The internal consistency of the protocol was 0.78. Delet-
ing the items “asymmetry” and “mandibular retrognathism”
with low agreement from the analyses, Cronbach’s alpha
reached 0.85.
Reliability of assessments: rheumatologist versus RE
Inter-observer reliability using Cohen’s Kappa of the
history related items varied between 0.46 and 0.87
(Table 2). Examination related items scored between
0.25 (asymmetry, retrognathia) and 0.73 (pain on opening).
Table 2 Reliability (Cohen’s Kappa) of the TMJ screening protocol assessments and prevalence of findings
Cohen’s Kappa Prevalence RE (%) Prevalence Rheumatologist (%)
History
Problems in chewing 0.46 10 16
Eating slower than others 0.45 14 22
Biting hard food 0.64 14 18
Pain while eating 0.83 14 15
Limited mouth opening 0.87 11 14
Examination
MMO limited* 0.42 12 15
Crepitation (audible) 0.0 5 7
Pain MMO 0.73 18 11
Deviation MMO (>2 mm) 0.31 7 15
Inspection
Asymmetry 0.25 22 19
Retrognathia 0.25 16 8
TMJ involv. RE vs Rha 0.46 54 51
ICC MMO Rh vs RE 0.61 (p < 0.01)
Δ MMORh - MMORE ≤7 mm [n (%)] 50 (67.6%)
μ Δ MMO Rh vs RE [mm] 0.9 (p = 0.35)
History related items (n = 5), examination related items (n = 4), and inspection related items (n = 2) compose the screening protocol. Intraclass correlation of the
rheumatologist and the reference examiner.
RE: reference examiner. ICC: intraclass coefficient.
*MMO limited: ≤ 35 mm (≤10 yrs); ≤ 40 mm (>10 yrs); a TMJ involvement based on the criterion ‘at least 1 positive score. μ =mean, p value Δ MMO
(Students t-test)
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The agreement between the rheumatologist and the RE
regarding the total score of the TMJ protocol was .46.
The mean MMO measured by the rheumatologist and
the RE did not differ significantly: 46.7 mm vs. 45.8 mm
(p = 0.35, Table 2). MMO measurements of the rheuma-
tologist and the RE correlated significantly (intraclass coeffi-
cient .61, p < 0.01, Table 2), with differences less than 7 mm
(smallest detectable change indicating clinical relevance) in
68 percent of the patients (Table 2). The MMO of children
under 10 years old did not differ significantly from the chil-
dren over 10 years old: 43.6 vs 46.3 respectively (p = 0.104,
Table 1).
The prevalence of positive clinical assessments by the
RE and the rheumatologist varied between 5 and 22 per-
cent (Table 2). In this study the maximum protocol
scores were 8 and 9 assessed by the RE and the rheuma-
tologist respectively.
The MMO measured by the rheumatologist correlated
negatively with JADAS-27 (p = 0.03, Table 3). The total
score of the RE and rheumatologist correlated (p < 0.01)
with JADAS-27; the composite scores of the five history
items and four examination items on mandibular func-
tion (asymmetry and micrognathia excluded) correlated
with JADAS-27 as well (Table 3).
Concurrent validity of the TMJ protocol used by the
rheumatologist
The JADAS-27 was used as an external reference, available
in 66 out of 74 patients. For eight patients ESR from a
former visit was used. Using a cut-off point of “at least 1
positive score”, the mean JADAS-27 of the resulting patient
groups was 2.0 (no TMJ involvement) vs 5.0 (TMJ involve-
ment) (p = 0.029, Table 4). Using the cut-off point “at least
2 positive scores,” the mean JADAS in the resultant patient
groups was 2.20 (no TMJ involvement) and 6.39 (TMJ in-
volvement) (p = 0.003, Table 4). This cut-off point resulted
in a potential TMJ involvement in 25 (34%) out of 74 pa-
tients (Table 4). Eleven out of these 25 patients (44%) with
potential TMJ involvement had a disease activity below
“3.8” (range 0.0 – 3.5). Ten of the 49 patients (20%) without
potential TMJ involvement had a disease activity above
“3.8” (range 3.9 – 12.4). The results of the other cut-off
points are presented in Table 4.
ROC analysis indicated sensitivity and specificity of
the TMJ protocol used by the rheumatologist of 0.52
and 0.80 respectively for a disease activity score of “3.8,”
with the area under the curve (AUC) 0.70.
Discussion
A screening instrument to assist rheumatologists in de-
termining TMJ involvement was tested. The internal
consistency was adequate. Cohen’s kappa values express-
ing reliability of the history and function related items
varied between 0.42 (fair) and 0.87 (almost perfect).
Concurrent validity was found to be fair to good. The
rheumatologists noted that the TMJ screening could eas-
ily be included in the regular consultation time, making
it applicable in standard clinical care such as follow-up.
Reliability
The internal consistency of the protocol could be raised to
0.85 by deleting “asymmetry” and “retrognathia” with low
internal correlations. However, because these variables
need to be evaluated in order to assess growth distur-
bances and for referral to an orthodontist and/or an oro-
maxillofacial surgeon, we propose that these two items
should be retained in the protocol despite the lower reli-
ability of the assessments.
A striking finding was the absence of major man-
dibular underdevelopment in this patient group. This
finding supports a decreased future demand for surgi-
cal correction at an adult age. Using the suggested cri-
terion of “at least 2 positive scores,” 34 percent of the
patients were identified as having potential TMJ in-
volvement (Table 4), which is close to the 42 percent
detected by using contrast enhanced MRI [4].
In this study one rheumatologist examined the major-
ity of the patients (n = 44). The other patients were
examined by three other rheumatologists. Their participa-
tion is not expected to disqualify our results regarding
agreement. Agreement studies indicate lower inter-
examiner agreement than intra-examiner agreement.
However in clinical settings the same rheumatologist
will perform repeated measurements in follow-up visits
and in such a scenario agreement is likely to be higher
than our results.
Limitation of MMO is traditionally perceived as a key
sign of TMJ involvement. Restricted mouth opening cap-
acity is found more often in patients with JIA with radio-
graphic signs of mandibular condyle lesions than in those
without any detectable lesions [18]. In our study MMO
and the JADAS-27 were negatively correlated, signifying
that disease activity is associated with mandibular function
Table 3 Pearson correlation of TMJ protocol variables
and JADAS-27 for the rheumatologist and the reference
examiner
Correlations Rh r (p) RE r (p)
Pain on MMO – JADAS-27 0.21 (0.08) 0.51 (<0.01)
Pain on chewing – JADAS-27 0.47 (<0.01) 0.19 (<0.01)
Total score – JADAS-27 0.34 (0.003) 0.49 (<0.01)
Fh° – JADAS-27 0.36 (<0.01) 0.47 (<0.01)
Fe* – JADAS-27 0.26 (0.03) 0.44 (<0.01)
MMO – JADAS-27 - 0.27 (0.03) - 0.23 (0.08)
°Fh: number of positive history scores on mandibular function; *Fe: number of
positive examination scores on mandibular function. Rh: rheumatologist; RE:
reference examiner; correlation r values; p: probability (Students t-test).
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(Table 3). TMJ deformity was not assessed in our study;
deformity represents earlier periods of disease activity,
whereas the JADAS-27 and the protocol for most of its
items indicate current disease activity. Using the protocol
with the criteria “at least 3 positive scores,” the mean
MMO was significantly lower (6.1 mm, p = 0.023) in JIA
patients with TMJ protocol scores above this cut-off value
compared to JIA patients with TMJ protocol scores lower
than or equal to this cut-off value, supporting construct
validity. For the criterion “at least 2 positive scores,” the
MMO difference trended towards significance (4.5 mm,
p = 0.076). These mean differences coincide with the smal-
lest detectable change for MMO (5–7 mm), suggesting
clinical relevance [19]. Follow-up measurements of MMO
in the context of the other items of the protocol allows for
detecting clinical relevant changes of this parameter. The
clinical relevance of discriminating restricted MMO by age
can be disputed as the criterion below 10 years of age and
over 10 years of age resulted in a non-significant difference
of MMO (2.7 mm).
Since all patients were examined first by the rheuma-
tologist, an order effect might have occurred. Considering
the non-significant differences in MMO measurements
between the rheumatologist and the RE, this effect is con-
sidered nonexistent (Table 3).
Validity
Since the JADAS-27 is a relatively new protocol, the scores
for defining minimal disease activity in JIA categories were
established only recently [15,20]. A cut-off in the disease ac-
tivity score of “3.8” was chosen as a good classifier for low
JIA disease activity in all JIA subtypes. The lower disease
activity score of “2” indicates the absence of disease activity
in the oligo articular subtype alone and was considered less
clinically relevant [16]. We originally conceptualized a
cut-off point of “at least 1 positive score” of the TMJ
protocol for TMJ involvement. The mean JADAS-27
score of the patient groups using that cut-off point was
2.0 vs 5.0 (Table 4). Because using the protocol with a
cut-off point of “at least 2 positive scores” resulted in a
larger contrast of the JADAS-27 (2.2 vs. 6.4), this cut-
off score seems to be a better indicator to decide about
TMJ involvement than ‘at least 1 positive score’. The
ROC analysis supported the use of “at least 2 positive
scores.” A cut-off disease activity score of “3.8” resulted
in a sensitivity and specificity of 0.57 and 0.77 respectively,
positive and negative predictive values being 0.52 and 0.80
respectively. The relative high percentage of oligo-articular
JIA with known low level TMJ involvement in our patient
group might contribute to the low sensitivity of the instru-
ment with 3 and 4 positive scores.
Table 4 Test characteristics of the TMJ protocol for different cut-off points; assessments by the rheumatologist
no TMJ involv. TMJ involv Sens Spec PPV NPV p
Protocol score
at least 1 pos score (n) 34 40
JADAS-27 (sd) 2.0 (2.98) 5.0 (7.13) 0.029
JADAS-27≥ 2 0.65 0.55 0.55 0.65
JADAS-27≥ 3.8 0.65 0.51 0.38 0.77
Protocol score
at least 2 pos scores (n) 49 25
JADAS-27 (sd) 2.2 (3.12) 6.39 (8.36) 0.003
JADAS-27≥ 2 0.47 0.78 0.64 0.63
JADAS-27≥ 3.8 0.57 0.77 0.52 0.80
Protocol score
at least 3 pos score (n) 60 14
JADAS-27 (sd) 2.37(3.14) 8.94 (10.2) < 0.001
JADAS-27≥ 2 0.41 0.85 0.70 0.63
JADAS-27≥ 3.8 0.52 0.84 0.60 0.80
Protocol score|
at least 4 pos scores (n) 64 10
JADAS-27 (sd) 3.31 (5.69) 5.56 (6.26) 0.306
JADAS-27≥ 2 0.18 0.90 0.60 0.56
JADAS-27≥ 3.8 0.22 0.90 0.50 0.72
JADAS-27: juvenile arthritis disease activity score. Sens: sensitivity; Spec: specificity; NPV: negative predictive value; PPV: positive predictive value. p: probability
(Students t-test).
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We used the JADAS-27 values at the time of the
examination in 66 patients. The other eight patients
were in complete remission. In these eight patients a
blood test wasn’t indicated on the day of examination
and the JADAS-27 was calculated using ESR values ori-
ginating from a period no longer than 3 months before
the examination. This approach allowed for the use of
the JADAS-27 in 74 patients.
Clinical considerations
Because the screening protocol for TMJ involvement
is applicable in standard clinical care it provides the
rheumatologist with systematic and focused TMJ informa-
tion which relates to the JIA disease activity (JADAS-27).
It is a tool to detect signs and symptoms of dysfunction of
the masticatory system. Diagnosing TMJ arthritis is not
possible with clinical assessment only, as indeed it can
exist in the absence of signs and symptoms. In order to
diagnose arthritis as early as possible, we investigated the
correlation between the protocol score and inflammatory
activity. Ideally TMJ arthritis should be detected with 100
percent certainty and this goal is approached by MRI [21].
Measuring disease activity as leading variable for manage-
ment decisions is another option, and is feasible and ap-
propriate in the clinic practice. A positive correlation
between the protocol score and the JADAS-27 offers add-
itional support for the protocol to be used at regular inter-
vals for identifying disease activity in the TMJ.
It is probable that MRI with contrast detects more
TMJ inflammation than the screening protocol detects
TMJ dysfunction. Nevertheless the clinical significance
of MRI contrast enhancement is not completely known,
as suggested by a recent study in which indeed TMJ
MRI enhancement is compatible with a normal range of
mouth opening, normal TMJ function, absence of arth-
ritis in other joints and may be present in the context of
immunosuppressive therapy [4]. The correlation of find-
ings resulting from the protocol and MRI findings (and
eventually other mandibular function variables like bite
force and masticatory performance) could result in more
clear indications for the use of MRI. This will be investi-
gated in future studies. In this regard, the rheumatologic
evaluation of the TMJ could start with the protocol
which is associated with disease activity through the use
of the JADAS-27 in a daily clinical setting and continue,
if indicated, with imaging, in order to define better treat-
ment and follow up.
Regarding disease activity, the JADAS-27 was used for
correlation with the TMJ protocol, because the TMJ
examination is not included in this score. If the TMJ
examination would have been included in the disease activ-
ity score like in the JADAS-71, the calculated correlation
with the TMJ protocol would be biased. The aim of the in-
vestigation was to test the validity of the protocol against a
reference score. We chose the disease activity JADAS-27 to
avoid circular reasoning. The JADAS-71 might be more
suitable as disease activity score from a clinical standpoint,
but methodological considerations predominated our
choice for the JADAS-27.
The cut-off value for reduced MMO has been sug-
gested throughout the literature as < 40 mm. However,
there are good reasons to consider values that are age-
related when examining the mandibular range of motion
in children. For that reason we used two cut-off scores
for children ≤ 10 years of age and > 10 years of age.
Measuring MMO, like we did, indicated a wide range of
MMO per age category in a population of 20709 school-
children [22]. The authors drew the conclusion from
their study that “the use of a cut-off point for the assess-
ment of MMO in children with potential affection of the
masticatory system could not be recommended.” The
authors state that even the percentiles “will not be able
to solve the dilemma of interpretation of a single MMO
measurement.” However they “hope that the percentile
charts will become an important tool for longitudinal
follow-up of children with a high risk for TMJ affections,
e.g. children with JIA.” The TMJ screening protocol
allows for regular measurement of mouth opening, de-
tection of changes in the range of motion over time, as
advocated by WHO for growth curves. In follow-up,
change might be more informative than the mere use of
a cut-off point. If a cut-off point is used, the interpret-
ation of range of motion measurements should always
be performed in the context of the patient. We did not
include lateral excursions as a clinical assessment. This
measure of the range of motion is more complex and
thus time consuming when executed properly. Asym-
metry with wide mouth opening (item number nine,
Figure 2b) is highly indicative of asymmetric lateral ex-
cursions. The assessment of the vertical overbite was
not included in measuring mouth opening since this
measurement is time consuming as well and does not
have additional clinical relevance regarding the clinical
entity “mouth opening” when comparing the results of
the interincisal distance between consecutive visits in
the same patients. Vertical open bites between the front
teeth may be indicators of condylar structural changes
and as such need to be documented beyond a screening
protocol.
Conclusion
The use of the screening TMJ protocol for the rheuma-
tologist is feasible in the everyday clinical practice. The
internal consistency of the protocol was good. Several
function related items regarding actual signs and symp-
toms of TMJ involvement in patients with JIA could be
scored with moderate to almost perfect reliability. Validity
using the JADAS-27 as an external reference indicates good
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clinical utility. Replication using the TMJ protocol in a lar-
ger patient group and the use of other external references
can provide additional validity of the TMJ protocol in de-
tecting TMJ involvement.
Consent
Written consent was obtained from the patient and the
parents for publication of Figure 2.
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